Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The weight loss achieved with GLP-1 therapy also reduces risks for heart disease, stroke, and type 2 diabetes, offsetting minor temporary discomfort
The dose-escalation schedule for Wegovy is fixed: Weeks 1-4: 0.25 mg subcutaneously once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12: 1.0 mg once weekly Weeks 13-16: 1.7 mg once weekly Week 17 onward: 2.4 mg once weekly (maintenance) GI side effects, including nausea, vomiting, and the delayed gastric emptying that complicates ibuprofen use, are most intense during dose escalation
Prescription medications: If appropriate, Our medical providers can prescribe weight loss medications, such as GLP-1 receptor agonists or other FDA-approved options, to support patients in achieving their weight loss goals
Will I experience withdrawal when I stop taking Mounjaro
